These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35259410)

  • 41. "I'll just deal with this on my own": a qualitative exploration of experiences with self-managed abortion in the United States.
    Raifman S; Ralph L; Biggs MA; Grossman D
    Reprod Health; 2021 May; 18(1):91. PubMed ID: 33947413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
    Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
    Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
    Chen MJ; Creinin MD
    Obstet Gynecol; 2015 Jul; 126(1):12-21. PubMed ID: 26241251
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early medical abortion using low-dose mifepristone followed by buccal misoprostol: a large Australian observational study.
    Goldstone P; Michelson J; Williamson E
    Med J Aust; 2012 Sep; 197(5):282-6. PubMed ID: 22938126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10weeks of pregnancy in Kazakhstan.
    Platais I; Tsereteli T; Grebennikova G; Lotarevich T; Winikoff B
    Int J Gynaecol Obstet; 2016 Sep; 134(3):268-71. PubMed ID: 27352735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A repeat dose of misoprostol 800 mcg following mifepristone for outpatient medical abortion at 64-70 and 71-77 days of gestation: A retrospective chart review.
    Dzuba IG; Castillo PW; Bousiéguez M; Lugo Hernández EM; Castañeda Vivar JJ; Sanhueza Smith P
    Contraception; 2020 Aug; 102(2):104-108. PubMed ID: 32474060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simultaneous compared to interval administration of mifepristone and misoprostol for medical abortion up to 10
    Schmidt-Hansen M; Lord J; Hasler E; Cameron S
    BMJ Sex Reprod Health; 2020 Oct; 46(4):270-278. PubMed ID: 32079651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Change in serum beta-human chorionic gonadotropin after abortion with methotrexate and misoprostol.
    Creinin MD
    Am J Obstet Gynecol; 1996 Feb; 174(2):776-8. PubMed ID: 8623820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of an at-home multilevel pregnancy test and an automated call-in system to follow-up the outcome of medical abortion.
    Anger H; Dabash R; Peña M; Coutiño D; Bousiéguez M; Sanhueza P; Winikoff B
    Int J Gynaecol Obstet; 2019 Jan; 144(1):97-102. PubMed ID: 30221366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extending outpatient medical abortion services through 70 days of gestational age.
    Winikoff B; Dzuba IG; Chong E; Goldberg AB; Lichtenberg ES; Ball C; Dean G; Sacks D; Crowden WA; Swica Y
    Obstet Gynecol; 2012 Nov; 120(5):1070-6. PubMed ID: 23090524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project.
    LaRoche KJ; Wylie A; Persaud M; Foster AM
    Contraception; 2022 May; 109():37-42. PubMed ID: 35031301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation.
    Li CL; Chen DJ; Deng YF; Song LP; Mo XT; Liu KJ
    Hum Reprod; 2015 Dec; 30(12):2794-801. PubMed ID: 26405260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Self-assessment of success of early medical abortion using a self-performed urine pregnancy test.
    Cameron S; Rowlands S; Gemzell-Danielsson K
    Eur J Contracept Reprod Health Care; 2019 Aug; 24(4):319-321. PubMed ID: 31204845
    [No Abstract]   [Full Text] [Related]  

  • 57. Safety, Efficacy and Acceptability of Early First Trimester Abortion using Oral Mifepristone and Sublingual Misoprostol.
    Shrestha D; Aryal S; Sharma B
    J Nepal Health Res Counc; 2018 Oct; 16(3):269-273. PubMed ID: 30455484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision.
    Wang G; Li D; Manconi F; Dong B; Zhang Y; Sun B
    Contraception; 2010 Jan; 81(1):62-6. PubMed ID: 20004275
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Can women accurately assess the outcome of medical abortion based on symptoms alone?
    Jackson AV; Dayananda I; Fortin JM; Fitzmaurice G; Goldberg AB
    Contraception; 2012 Feb; 85(2):192-7. PubMed ID: 22067786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ovulation resumption after medical abortion with mifepristone and misoprostol.
    Schreiber CA; Sober S; Ratcliffe S; Creinin MD
    Contraception; 2011 Sep; 84(3):230-3. PubMed ID: 21843685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.